000 01673 a2200493 4500
005 20250517151028.0
264 0 _c20180404
008 201804s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.16321
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSlobbe, Paul
245 0 0 _aDevelopment of [11C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts.
_h[electronic resource]
260 _bOncotarget
_cJun 2017
300 _a38337-38350 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCarbon Radioisotopes
_xpharmacokinetics
650 0 4 _aCell Line, Tumor
650 0 4 _aHeterografts
650 0 4 _aHumans
650 0 4 _aIndoles
_xpharmacokinetics
650 0 4 _aMelanoma
_xdiagnostic imaging
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aMutation
650 0 4 _aPatient Selection
650 0 4 _aPositron-Emission Tomography
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aRadioactive Tracers
650 0 4 _aRadiopharmaceuticals
_xpharmacokinetics
650 0 4 _aSulfonamides
_xpharmacokinetics
650 0 4 _aTissue Distribution
650 0 4 _aVemurafenib
700 1 _aWindhorst, Albert D
700 1 _aAdamzek, Kevin
700 1 _aBolijn, Marije
700 1 _aSchuit, Robert C
700 1 _aHeideman, Daniƫlle A M
700 1 _avan Dongen, Guus A M S
700 1 _aPoot, Alex J
773 0 _tOncotarget
_gvol. 8
_gno. 24
_gp. 38337-38350
856 4 0 _uhttps://doi.org/10.18632/oncotarget.16321
_zAvailable from publisher's website
999 _c27090033
_d27090033